Prospects for hyperthermia in human cancer therapy. Part II: implications of biological and physical data for applications of hyperthermia to man.
Laboratory data from studies of hyperthermia as a potential antitumor agent indicate that: (a) tumor cells may be more sensitive to heat than normal tissue; (b) hyperthermia enhances response to irradiation and can increase the therapeutic ratio; (c) cells are most sensitive to hyperthermia during the S-phase, when they are resistant to ionizing radiations; (d) the oxygen effect is absent for hyperthermic cell killing, and radiation effects are less oxygen-dependent when potentiated by heat treatment; and (e) biological damage changes more rapidly at temperatures above 43 degrees C. Methods of heat production and dosimetry need to be refined further before these findings can be put to practical use in tumor therapy.
D000818:Animals; D001831:Body Temperature; D002455:Cell Division / Q000528:radiation effects; D004261:DNA Replication; D004273:DNA, Neoplasm / Q000528:radiation effects; D003972:Diathermy; D004599:Electric Stimulation Therapy; D006979:Hyperthermia, Induced; D007101:Immersion; D008872:Microwaves / Q000627:therapeutic use; D009369:Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D010100:Oxygen; D010477:Perfusion; D011879:Radiotherapy Dosage; D007507:Therapeutic Irrigation; D013821:Thermometers; D014464:Ultrasonic Therapy; D014964:X-Ray Therapy
D004273:DNA, Neoplasm; D010100:Oxygen